Trial Outcomes & Findings for SB3 Battery Life Observational Study (NCT NCT02382705)
NCT ID: NCT02382705
Last Updated: 2019-04-02
Results Overview
rate at which small bowel is completely examined (capsule endoscopy enters cecum)
Recruitment status
COMPLETED
Target enrollment
57 participants
Primary outcome timeframe
0.1 - 12 hours
Results posted on
2019-04-02
Participant Flow
Participant milestones
| Measure |
PillCam SB3EX
All participants in the study used the PillCam SB3EX for their capsule endoscopy
|
|---|---|
|
Overall Study
STARTED
|
57
|
|
Overall Study
COMPLETED
|
33
|
|
Overall Study
NOT COMPLETED
|
24
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
PillCam SB3EX
n=57 Participants
All participants in the study used the PillCam SB3EX for their capsule endoscopy
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=57 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
42 Participants
n=57 Participants
|
|
Age, Categorical
>=65 years
|
15 Participants
n=57 Participants
|
|
Age, Continuous
|
53.6 years
STANDARD_DEVIATION 15.7 • n=57 Participants
|
|
Sex: Female, Male
Female
|
28 Participants
n=57 Participants
|
|
Sex: Female, Male
Male
|
29 Participants
n=57 Participants
|
|
Region of Enrollment
Canada
|
57 participants
n=57 Participants
|
PRIMARY outcome
Timeframe: 0.1 - 12 hoursrate at which small bowel is completely examined (capsule endoscopy enters cecum)
Outcome measures
| Measure |
PillCam SB3EX
n=57 Participants
|
|---|---|
|
Completion Rate (Rate at Which Small Bowel is Completely Examined)
|
57 Participants
|
SECONDARY outcome
Timeframe: 0.1 - 12 hoursrate at which a pathological finding is identified on capsule endoscopy
Outcome measures
| Measure |
PillCam SB3EX
n=57 Participants
|
|---|---|
|
Diagnostic Yield
|
20 Participants
|
SECONDARY outcome
Timeframe: 0.1 - 12 hourstime it takes for capsule camera to traverse the stomach
Outcome measures
| Measure |
PillCam SB3EX
n=33 Participants
|
|---|---|
|
Gastric Transit Time
|
37.6 minutes
Standard Deviation 92.1
|
SECONDARY outcome
Timeframe: 0.1 - 12 hourstimes it takes for capsule camera to traverse the entire small bowel.
Outcome measures
| Measure |
PillCam SB3EX
n=33 Participants
|
|---|---|
|
Small Bowel Transit Time
|
232.1 minutes
Standard Deviation 98.3
|
Adverse Events
PillCam SB3EX
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place